 |
|
|
| |
Pharmacokinetics and Safety Data After Switching From Injectable CAB + RPV to Oral B/F/TAF
|
| |
| |
20th European AIDS Conference (EACS); October 15-18, 2025; Paris, France
Priyanka Arora1, Moti Ramgopal2, Thomas CS Martin3, Hui Liu1, Jason T Hindman1, Jason Okulicz1, Dhananjay D Marathe1, Samir Gupta4
1Gilead Sciences, Inc., Foster City, CA, USA; 2Midway Immunology and Research Center, Fort Pierce, FL, USA; 3University of California San Diego, San Diego, CA, USA; 4Indiana University School of Medicine, Indianapolis, IN, USA
|
| |
|
|
|
|
|
